About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the benefit of humanity.
https://weizmann-usa.org/blog/ebola-is-still-killing-people-can-new-vaccines-help/
Aug 27, 2019...
Warning, again: While not making global headlines like it used to, Ebola rages on. A sign in the Congo warns that Ebola is in the area and to avoid dead animals, which are a vector for the virus.
The massive 2014-16 outbreak of Ebola in Africa was the first time many of us had heard of the virus. The stories and images of horribly sick and dying people, the selfless doctors and nurses in their too-often-insufficient protective gear, the concern that the virus’s spread could not be stopped: for a while, Ebola was in the global consciousness. Then, thanks to efforts on a number of fronts, the outbreak was quashed. Our attention faded accordingly.
https://weizmann-usa.org/blog/medical-marijuana-born-at-weizmann/
Oct 04, 2019...
Meet the man: Raphael Mechoulam’s research has driven the current medical marijuana boom – and is helping people suffering from a host of conditions
As the wave of marijuana legalization washes across America, THC and CBD products are suddenly everywhere: gummy bears, energy drinks, chocolate, even skin-care products.
Before laws were changed, scientists in the U.S. were handicapped in their ability to research marijuana, thus giving a decades-long edge to scientists elsewhere. Scientists like Prof. Raphael Mechoulam at Israel’s Weizmann Institute. Having obtained drugs for research from the police for over 40 years (one of his many fascinating stories), he says: “Most of the pharmacists working at the Ministry are my ex-students. Working in a small country certainly has its positive aspects.”
Mar 20, 2020...
Dear friends and members of the Weizmann Institute of Science community,
The coronavirus outbreak is a global challenge that forces us all to significantly and rapidly adjust our way of life and change our work routines.
Just a few months ago we might have imagined such an event playing out only in books or movies. But epidemiologists, immunologists, and public health officials have long anticipated the possibility of a pandemic. The theoretical policies developed during these more peaceful days are now being implemented worldwide to address the current crisis.
Apr 01, 2020...
JERUSALEM — Teams of epidemiologists and computer scientists on three continents have started mass population surveys to try to get ahead of the coronavirus and ensure that scarce diagnostic tests, and even scarcer ventilators, are sent where they can do the most good.
More than two million people in Britain and 150,000 Israelis have already completed simple questionnaires, and many are updating their answers daily. Analysts of the data — including symptoms of Covid-19 and test results, as well as risk factors and demographics — say they have been able to identify incipient outbreaks days ahead of the authorities.
Mar 19, 2020... REHOVOT, ISRAEL—March 17, 2020—In light of the severe constraints in performing a sufficient amount of coronavirus tests in Israel, the Weizmann Institute of Science has decided to contribute significantly to the national mission and use its advanced laboratories to perform coronavirus tests. In parallel, Weizmann Institute scientists are developing an advanced and very efficient testing approach that has a significantly reduced risk.
https://weizmann-usa.org/news-media/news-releases/intermittent-lockdown/
Mar 31, 2020... REHOVOT, ISRAEL—March 31, 2020—Think of dieting. You can fast for two months and lose weight, but you will probably die. Even if you survive, you will quickly gain weight again. Similarly, a two-month lockdown will suppress the coronavirus, but it will kill the economy. Lockdown will push hundreds of millions of people globally into unemployment and poverty. Many sectors of the economy will collapse. At the end of each lockdown, remaining patients will cause a resurge in the epidemic, forcing another lockdown.
Aug 28, 2019... Did you know that malaria kills about half a million people each year? In the eighth episode of Weizmann in Focus, CEO Dave Doneson explains how Weizmann is helping to fight this terrible disease. Using computer-based tools, PhD student Adi Goldenzweig developed a groundbreaking malaria vaccine in the lab of Dr. Sarel Fleishman. Because the vaccine is inexpensive to produce and does not require refrigeration, it has the potential to help millions of people in developing countries where the battle against malaria is particularly devastating.
Apr 27, 2020... On May 2, 1986, while visiting my long-term colleague and friend Richard O’Reilly, the head of bone marrow transplantation at Memorial Sloan Kettering Cancer Center in New York, I received a strange phone call. It was from Richard Champlin, who worked at the Bone Marrow Transplant Center at UCLA. He tended to speak very fast, so it took me some time to understand from his over-excited voice that he was about to leave the next day for Moscow.
https://weizmann-usa.org/news-media/feature-stories/coronavirus-testing-at-the-weizmann-institute/
Apr 21, 2020... One of the many challenges facing humankind during the coronavirus pandemic is testing – or, more accurately, lack of it. As the Weizmann Institute of Science pivoted its resources – human and lab alike – to addressing coronavirus, developing accurate, scaled-up testing was one of its main areas of focus. In keeping with the philosophy embraced by the worldwide Weizmann family, Institute President Prof. Alon Chen says: “During this crisis, we are harnessing our capabilities in basic research and applying them to the benefit of humanity.”
Aug 13, 2020... Hosted by the Embassy of Israel to the United States, this engaging virtual dialogue features Weizmann Institute President Prof. Alon Chen in conversation with Tammy Ben Haim, Minister of Public Diplomacy. Prof. Chen and Minister Ben Haim discuss a wide array of topics, including the Weizmann Institute's rapid response to the coronavirus. Prof. Chen explains how Weizmann's collaborative, multidisciplinary approach and focus on fundamental, curiosity-driven research enabled its scientists to quickly mobilize to fight COVID-19.
©2022 American Committee for the Weizmann Institute of Science
FOR THE FOURTH CONSECUTIVE YEAR